Corcept Therapeutics (CORT) Earnings Date, Estimates & Call Transcripts

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Free cort Stock Alerts

$22.66

-0.34 (-1.48%)

(As of 04/18/2024 ET)

Compare

Upcoming Earnings Date: May. 1Estimated
Actual EPS (Feb. 15): $0.28 Beat By $0.03
Consensus EPS (Feb. 15): $0.25

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

CORT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CORT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

Corcept Therapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	4	($0.02)	$0.31	$0.15
Q2 2024	4	($0.05)	$0.36	$0.18
Q3 2024	4	($0.08)	$0.38	$0.17
Q4 2024	4	($0.09)	$0.46	$0.22
FY 2024	16	($0.24)	$1.51	$0.72
Q1 2025	1	$0.21	$0.21	$0.21
Q2 2025	1	$0.26	$0.26	$0.26
Q3 2025	1	$0.26	$0.26	$0.26
Q4 2025	1	$0.40	$0.40	$0.40
FY 2025	4	$1.13	$1.13	$1.13
Q1 2026	1	$0.39	$0.39	$0.39

CORT Earnings Date and Information

Corcept Therapeutics last posted its earnings results on February 15th, 2024. The biotechnology company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.03. The firm had revenue of $135.41 million for the quarter, compared to analysts' expectations of $129.27 million. Its revenue was up 31.4% on a year-over-year basis. Corcept Therapeutics has generated $0.95 earnings per share over the last year ($0.95 diluted earnings per share) and currently has a price-to-earnings ratio of 23.9. Earnings for Corcept Therapeutics are expected to grow by 43.48% in the coming year, from $0.92 to $1.32 per share. Corcept Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.

Corcept Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/1/2024 Estimated)	-	-	-	-	-	-	-
2/15/2024	Q4 2023	$0.25	$0.28	+$0.03	$0.28	$129.27 million	$135.41 million
11/1/2023	Q3 2023	$0.22	$0.28	+$0.06	$0.28	$119.71 million	$123.60 million
8/2/2023	Q2 2023	$0.15	$0.25	+$0.10	$0.25	$109.60 million	$117.72 million
5/3/2023	Q1 2023	$0.20	$0.14	($0.06)	$0.14	$104.91 million	$105.70 million
2/28/2023	Q4 2022	$0.23	$0.14	($0.09)	$0.14	$106.93 million	$103.06 million
11/3/2022	Q3 2022	$0.23	$0.30	+$0.07	$0.30	$107.73 million	$101.73 million
Get the Latest News and Ratings for CORT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corcept Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/3/2022	Q2 2022	$0.25	$0.24	($0.01)	$0.24	$101.51 million	$103.39 million
5/5/2022	Q1 2022	$0.23	$0.20	($0.03)	$0.20	$103.23 million	$93.70 million
2/15/2022	Q4 2021	$0.22	$0.26	+$0.04	$0.26	$101.17 million	$98.82 million
11/3/2021	Q3 2021	$0.19	$0.24	+$0.05	$0.24	$97.75 million	$96.13 million
7/29/2021	Q2 2021	$0.14	$0.21	+$0.07	$0.21	$85.83 million	$91.59 million
5/6/2021	Q1 2021	$0.21	$0.18	($0.03)	$0.18	$96.99 million	$79.44 million

Corcept Therapeutics Earnings - Frequently Asked Questions

When is Corcept Therapeutics's earnings date?: Corcept Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on CORT's earnings history.
Did Corcept Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Corcept Therapeutics (NASDAQ:CORT) reported $0.28 earnings per share (EPS) to beat the analysts' consensus estimate of $0.25 by $0.03. Learn more on analysts' earnings estimate vs. CORT's actual earnings.
How can I listen to Corcept Therapeutics's earnings conference call?: The conference call for Corcept Therapeutics's latest earnings report can be listened to online. Listen to Conference Call
How can I read Corcept Therapeutics's conference call transcript?: The conference call transcript for Corcept Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Corcept Therapeutics generate each year?: Corcept Therapeutics (NASDAQ:CORT) has a recorded annual revenue of $482.38 million.
How much profit does Corcept Therapeutics generate each year?: Corcept Therapeutics (NASDAQ:CORT) has a recorded net income of $106.14 million. CORT has generated $0.95 earnings per share over the last four quarters.
What is Corcept Therapeutics's price-to-earnings ratio?: Corcept Therapeutics (NASDAQ:CORT) has a trailing price-to-earnings ratio of 23.85 and a forward price-to-earnings ratio of 24.63.
What is Corcept Therapeutics's EPS forecast for next year?: Corcept Therapeutics's earnings are expected to grow from $0.92 per share to $1.32 per share in the next year, which is a 43.48% increase.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:CORT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Corcept Therapeutics (CORT) Earnings Date, Estimates & Call Transcripts

CORT Earnings Estimates and Actuals by Quarter

CORT Estimated and Actual Revenue by Quarter

Corcept Therapeutics Analyst EPS Estimates

CORT Earnings Date and Information

Corcept Therapeutics Earnings History by Quarter

Corcept Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Corcept Therapeutics (CORT) Earnings Date, Estimates & Call Transcripts

Earnings Summary

CORT Earnings Estimates and Actuals by Quarter

CORT Estimated and Actual Revenue by Quarter

Corcept Therapeutics Analyst EPS Estimates

CORT Earnings Date and Information

Corcept Therapeutics Earnings History by Quarter

Corcept Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat